Revenue has steadily increased from approximately $83.6 million in 2023 to over $129 million forecasted for 2025, showing strong top-line growth. Profitability has improved from consistent negative operating income in 2023 to positive operating income and net income in recent quarters of 2026. EBITDA margins recovered from -3.9% in 2023 to just below 4% in the latest quarter.

Revenue gains are driven by increased market adoption and expanding sales activities, supported by growing product acceptance in healthcare. The cost of revenue has risen proportionally but gross margins have remained relatively stable around 62-65%, reflecting efficient production and pricing power.

Gross margins are strong and consistent around 64%, while operating margins improved from negative to low single-digit positive territory recently. SG&A expenses remain high but are justified by sales growth efforts. EBITDA margins remain thin but positive, highlighting ongoing operational leverage.

Earnings quality is improving with better operating income generation and controlled interest expenses. However, the slight EPS decline in the most recent quarter is tied to a modest revenue shortfall and elevated selling expenses, indicating some short-term volatility but overall sustainability of earnings growth.

Year-over-year revenue growth has been robust, increasing roughly 23% from 2023 to 2025, and the quarterly comparisons show sequential moderation with Q2 2026 revenue down about 5.4% from Q1 2026. The longer-term trend shows solid double-digit growth.

Net income has turned positive and expanded substantially from negative levels in 2023, with Q1 2026 net income of $6.3 million compared to a loss in the prior year. EPS rose from -$0.07 to positive $0.01 recently, showing improving profitability despite quarter-to-quarter fluctuations.

Growth is driven by increasing product demand, expanded sales and marketing efforts, and steady R&D investment sustaining product innovation. The company’s ability to monetize its technological platform also fuels expansion.

Growth appears organic with consistent operational improvements rather than acquisition-driven. Maintaining high gross margins and controlled expenses supports growth sustainability, although cyclicality and competitive pressures remain risks.

Gross margin has remained robust near 64%, while operating margin improved from negative 6.7% in 2023 to low positive margins around 2-5% in recent quarters. Net income margin improved from -5.9% to positive 3.2% recently.

While explicit ROE and ROA metrics are unavailable, increasing net income and margin improvements imply improving returns on equity and assets aligned with the company's growing profitability.

Margins appear sustainable given stable cost of revenue and disciplined expense management. However, volatility in sales and marketing expenses suggest some caution in expecting steady margin expansion.